A phase four clinical trial to evaluate the safety and efficacy of glenmark Aprezo® (apremilast) in subjects with active psoriatic arthritis

Authors
Category Primary study
JournalIndian Journal of Rheumatology
Year 2023
This article has no abstract
Epistemonikos ID: d49179de11df9bdfccf8f6cb58df210617308dbd
First added on: Feb 17, 2025